Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth

Khalid Bajou; Catherine Maillard; Maud Jost; Roger Lijnen; Ann Gils; Paul Declerck; Peter Carmeliet; Jean-Michel Foidart; Agnès Noël

doi:10.1038/sj.onc.1207859

Related publications

Article1997

Small, Dense LDL Particle Concentration Correlates with Plasminogen Activator Inhibitor Type-1 (PAI-1) Activity

Sari Väisänen, Manfred W. Baumstark, Ilkka Penttilä, Claude Bouchard, Pirjo Halonen, Tuomo Rankinen, Aloys Berg, Rainer Rauramaa

Thrombosis and Haemostasis

Article2000

Paradoxical increase of plaque growth and collagen deposition in atherosclerotic mice lacking plasminogen activator inhibitor-1 (PAI-1)

Aernout Luttun, J‐M. Herbert, Lieve Moons, Peter G. Tipping, D Collen, Florea Lupu, Peter Carmeliet

Article2001

The Plasminogen Activator Inhibitor PAI-1 Controls in Vivo Tumor Vascularization by Interaction with Proteases, Not Vitronectin

Khalid Bajou, Véronique Masson, Robert D. Gerard, Petra M. Schmitt, Valérie Albert, Michael Praus, Leif R. Lund, Thomas Leth Frandsen, Nils Brünner, Keld Danø, Norbert E. Fusenig, Ulrich H. Weidle, Geert Carmeliet, David J. Loskutoff, D Collen, Peter Carmeliet, Jean‐Michel Foidart, Agnès Noël

Article1999

Regular Exercise, Plasminogen Activator Inhibitor-1 (PAI-1) Activity and the 4G/5G Promoter Polymorphism in the PAI-1 Gene

Sari Väisänen, Steve E. Humphries, L A Luong, I Penttilä, Claude Bouchard, R. Rauramaa

Thrombosis and Haemostasis

Article2006

Plasminogen activator inhibitor type I (PAI-1) controls bone marrow-dependent and independent vascularization

Maud Jost, Catherine Maillard, Vincent Lambert, Marc Tjwa, Pierre Blaise, Julie Lecomte, Khalid Bajou, Silvia Blacher, Patrick Motté, Chantal Humblet, Marie Paule Defresne, Marc Thiry, Françis Frankenne, André Gothot, Peter Carmeliet, Jean‐Marie Rakic, Jean‐Michel Foidart, Agnès Noël